Skip to main content
Log in

Emergency treatment of acute ischemic stroke: Expanding the time window

Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Intravenous thrombolysis has been shown to improve outcome in patients with ischemic stroke if given within the first 3 hours. This benefit extends into a 4.5-hour time window when applied in a more selected patient population. Strokes from large-vessel intracranial occlusion carry high morbidity and respond poorly to intravenously administered thrombolytics. Endovascular therapy should therefore be considered in patients who fail or have contraindications for intravenous thrombolysis, or who present within a time window of 4.5 to 8 hours, and perhaps up to 12 to 24 hours for basilar occlusions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References and Recommended Reading

  1. Katzan IL, Hammer MD, Furlan AJ, et al.: Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update. Stroke 2003, 34:799–800.

    Article  CAS  PubMed  Google Scholar 

  2. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995, 333:1581–1587.

  3. Marler JR, Tilley BC, Lu M, et al.: Early stroke treatment associated with better outcome: the NINDS rt-PA Stroke Study. Neurology 2000, 55:1649–1655.

    CAS  PubMed  Google Scholar 

  4. Hacke W, Kaste M, Fieschi C, et al.: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995, 274:1017–1025.

    Article  CAS  PubMed  Google Scholar 

  5. Hacke W, Kaste M, Fieschi C, et al.: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998, 352:1245–1251.

    Article  CAS  PubMed  Google Scholar 

  6. Clark WM, Albers GW, Madden KP, Hamilton S: The rtPA (alteplase) 0-to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Stroke 2000, 31:811–816.

    CAS  PubMed  Google Scholar 

  7. Clark WM, Wissman S, Albers GW, et al.: Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999, 282:2019–2026.

    Article  CAS  PubMed  Google Scholar 

  8. Hacke W, Donnan G, Fieschi C, et al.: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004, 363:768–774.

    Article  PubMed  Google Scholar 

  9. Hacke W, Kaste M, Bluhmki E, et al.: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008, 359:1317–1329.

    Article  CAS  PubMed  Google Scholar 

  10. Wahlgren N, Ahmed N, Davalos A, et al.: Thrombolysis with alteplase 3–4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008, 372:1303–1309.

    Article  CAS  PubMed  Google Scholar 

  11. del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr: Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator. a science advisory from the American Heart Association/American Stroke Association. Stroke 2009, 40:2945–2948.

    Article  PubMed  Google Scholar 

  12. Saver JL: Time is brain—quantified. Stroke 2006, 37:263–266.

    Article  PubMed  Google Scholar 

  13. Copen WA, Rezai Gharai L, Barak ER, et al.: Existence of the diffusion-perfusion mismatch within 24 hours after onset of acute stroke: dependence on proximal arterial occlusion. Radiology 2009, 250:878–886.

    Article  PubMed  Google Scholar 

  14. Thomalla G, Schwark C, Sobesky J, et al.: Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke 2006, 37:852–858.

    Article  PubMed  Google Scholar 

  15. Kohrmann M, Juttler E, Fiebach JB, et al.: MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol 2006, 5:661–667.

    Article  PubMed  Google Scholar 

  16. Schellinger PD, Thomalla G, Fiehler J, et al.: MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke 2007, 38:2640–2645.

    Article  PubMed  Google Scholar 

  17. Albers GW, Thijs VN, Wechsler L, et al.: Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006, 60:508–517.

    Article  PubMed  Google Scholar 

  18. Davis SM, Donnan GA, Parsons MW, et al.: Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008, 7:299–309.

    Article  PubMed  Google Scholar 

  19. Hacke W, Albers G, Al-Rawi Y, et al.: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005, 36:66–73.

    Article  CAS  PubMed  Google Scholar 

  20. Furlan AJ, Eyding D, Albers GW, et al.: Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006, 37:1227–1231.

    Article  CAS  PubMed  Google Scholar 

  21. Hacke W: The results of the joint analysis of two phase II trials on desmoteplase in acute ischemic stroke with treatment 3 to 9 hours after stroke onset. Presented at the 14th European Stroke Conference. Bologna, Italy; May, 2005.

  22. Hacke W, Furlan AJ, Al-Rawi Y, et al.: Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009, 8:141–150.

    Article  CAS  PubMed  Google Scholar 

  23. Wang Y, Liao X, Zhao X, et al.: Imaging-based thrombolysis trial in acute ischemic stroke-II (ITAIS-II). Int J Stroke 2009, 4:49–53.

    Article  PubMed  Google Scholar 

  24. Smith WS: Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006, 27:1177–1182.

    CAS  PubMed  Google Scholar 

  25. Nogueira RG, Smith WS; MERCI and Multi MERCI Writing Committee: Safety and efficacy of endovascular thrombectomy in patients with abnormal hemostasis: pooled analysis of the MERCI and Multi MERCI trials. Stroke 2009, 40:516–522.

    Article  PubMed  Google Scholar 

  26. Smith WS, Sung G, Starkman S, et al.: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005, 36:1432–1438.

    Article  PubMed  Google Scholar 

  27. Smith WS, Sung G, Saver J, et al.: Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008, 39:1205–1212.

    Article  PubMed  Google Scholar 

  28. del Zoppo GJ, Higashida RT, Furlan AJ, et al.: PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998, 29:4–11.

    PubMed  Google Scholar 

  29. Furlan A, Higashida R, Wechsler L, et al.: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282:2003–2011.

    Article  CAS  PubMed  Google Scholar 

  30. Ogawa A, Mori E, Minematsu K, et al.: Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 2007, 38:2633–2639.

    Article  CAS  PubMed  Google Scholar 

  31. Wechsler LR, Roberts R, Furlan AJ, et al.: Factors influencing outcome and treatment effect in PROACT II. Stroke 2003, 34:1224–1229.

    Article  PubMed  Google Scholar 

  32. Smith WS: Intra-arterial thrombolytic therapy for acute basilar occlusion: pro. Stroke 2007, 38:701–703.

    Article  PubMed  Google Scholar 

  33. Alberts MJ, Hademenos G, Latchaw RE, et al.: Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000, 283:3102–3109.

    Article  CAS  PubMed  Google Scholar 

  34. Alberts MJ, Latchaw RE, Selman WR, et al.: Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005, 36:1597–1616.

    Article  PubMed  Google Scholar 

  35. IMS Study Investigators: Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004, 35:904–911.

    Article  Google Scholar 

  36. The Interventional Management of Stroke (IMS) II Study. Stroke 2007, 38:2127–2135.

  37. Tomsick T, Broderick J, Carrozella J, et al.: Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol 2008, 29:582–587.

    Article  CAS  PubMed  Google Scholar 

  38. Bose A, Henkes H, Alfke K, et al.: The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008, 29:1409–1413.

    Article  CAS  PubMed  Google Scholar 

  39. McDougall C, Clark W, Mayer T, et al.: The Penumbra Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in acute ischemic stroke. Presented at the International Stroke Conference. New Orleans, LA; February 20–22, 2008.

  40. Nogueira RG, Yoo AJ, Buonanno FS, Hirsch JA: Endovascular approaches to acute stroke, part 2: a comprehensive review of studies and trials. AJNR Am J Neuroradiol 2009, 30:859–875.

    Article  CAS  PubMed  Google Scholar 

  41. Khatri P, Abruzzo T, Yeatts SD, et al.: Good outcome after technically successful intra-arterial therapy is time-dependent. Stroke 2008, 39:560.

    Article  Google Scholar 

  42. Nogueira RG, Liebeskind DS, Sung G, et al.: Predictors of clinical outcomes in acute ischemic stroke patients undergoing thrombectomy: pooled analysis of the MERCI and Multi MERCI Trials. Stroke 2009, 40:26.

    Article  Google Scholar 

  43. Khatri P, Hill MD, Palesch YY, et al.: Methodology of the Interventional Management of Stroke III Trial. Int J Stroke 2008, 3:130–137.

    Article  PubMed  Google Scholar 

  44. Molyneux A, Rothwell P: Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE): mechanical thrombectomy or revascularisation for acute ischaemic stroke. Plans for a prospective randomised trial. Presented at the 29th ABC-WIN Seminar. Val d’Isere, France; 2009.

  45. Fink JN, Kumar S, Horkan C, et al.: The stroke patient who woke up: clinical and radiological features, including diffusion and perfusion MRI. Stroke 2002, 33:988–993.

    Article  PubMed  Google Scholar 

  46. Todo K, Moriwaki H, Saito K, et al.: Early CT findings in unknown-onset and wake-up strokes. Cerebrovasc Dis 2006, 21:367–371.

    Article  PubMed  Google Scholar 

  47. Adams HP Jr, Leira EC, Torner JC, et al.: Treating patients with “wake-up” stroke: the experience of the AbESTT-II trial. Stroke 2008, 39:3277–3282.

    Article  PubMed  Google Scholar 

  48. Barreto AD, Martin-Schild S, Hallevi H, et al.: Thrombolytic therapy for patients who wake-up with stroke. Stroke 2009, 40:827–832.

    Article  CAS  PubMed  Google Scholar 

  49. Cho AH, Sohn SI, Han MK, et al.: Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. A preliminary report. Cerebrovasc Dis 2008, 25:572–579.

    Article  CAS  PubMed  Google Scholar 

  50. Jovin T, Gupta R, Liebeskind D, et al.: Imaging based intraarterial treatment for acute anterior circulation ischemic stroke due to intracranial large vessel occlusion beyond 8 hours from symptoms onset — preliminary multicenter experience. Presented at the 61st Annual Meeting of the American Academy of Neurology. Seattle, WA; April 29–May 2, 2009.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wade S. Smith.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nogueira, R.G., Smith, W.S. Emergency treatment of acute ischemic stroke: Expanding the time window. Curr Treat Options Neurol 11, 433–443 (2009). https://doi.org/10.1007/s11940-009-0047-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-009-0047-z

Keywords

Navigation